1,500
Participants
Start Date
August 31, 2025
Primary Completion Date
November 30, 2026
Study Completion Date
November 30, 2026
InfectID-BSI (Bloodstream Infection) qPCR Assay
"InfectID-BSI technology targets nucleic acid sequences unique to the target analyte. The qPCR raw data collected from InfectID-BSI's 9 assay tubes is analysed by Microbio's InfectID-Client (InfectID-BSI-associated software) and the result is reported as an analyte-detection if the unique target analyte is present or no result if the unique target analyte is absent.~InfectID-BSI is carried out with whole blood from a venous puncture (EDTA). DNA is extracted from a sample of the collected blood using a validated DNA extraction instrument according to the manufacturer's instructions. The extracted DNA is then added to the InfectID-BSI qPCR reagent panel which consists of 9 reaction tubes (6 for bacteria, and 3 for yeast species). The panel is subjected to real-time qPCR using a process of Melt Curve analysis using the Rotor-Gene Q MDx qPCR instrument. The assay report identifies the species present in the sample upon completion. Results are generated within 3 hours."
The Prince Charles Hospital, Chermside
The Princess Alexandra Hospital, Woolloongabba
University of Maryland, Baltimore
Vanderbilt University Medical Centre, Nashville
Indiana University Hospital, Indianapolis
Texas Children's Hospital, Houston
TriCore Reference Laboratories, Albuquerque
Southwest Regional Laboratory, UK Health Security Agency, Bristol UK, Bristol
Microbio Co Ltd
INDUSTRY